|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/68 | |
| A61K 31/519 | |||
| A61K 31/53 | |||
| A61K 45/06 | |||
| A61P 35/00 |
| (11) | Number of the document | 3268490 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16710115.3 |
| Date of filing the European patent application | 2016-03-07 | |
| (97) | Date of publication of the European application | 2018-01-17 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/054727 |
| Date | 2016-03-07 |
| (87) | Number | WO 2016/142312 |
| Date | 2016-09-15 |
| (30) | Number | Date | Country code |
| 201562130418 P | 2015-03-09 | US |
| (72) |
LIU, Ningshu, DE
PENA, Carol, US
JEFFERS, Michael, US
GENVRESSE, Isabelle, DE
|
| (73) |
Bayer Pharma Aktiengesellschaft,
Müllerstrasse 178, 13353 Berlin,
DE
Bayer Healthcare Pharmaceuticals Inc., 100 Bayer Boulevard, Whippany, New Jersey 07981, US |
| (54) | SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE-CONTAINING COMBINATIONS |
| SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE-CONTAINING COMBINATIONS |